| Summary: | Abstract.: Lung fibroblasts are responsible for collagen secretion during normal tissue repair and the development of fibrosis. Many other prostaglandins have been reported to regulate collagen synthesis in lung fibroblasts, but the role of prostaglandin D2 (PGD2) is unknown. In this study, we investigated the effect of PGD2 on type I collagen secretion in human lung fibroblasts. Pretreatment with PGD2 (0.1 – 10 μM, 1 h) significantly attenuated type I collagen secretion to the cell supernatant induced by transforming growth factor-β (TGF-β). Although an agonist on chemoattractant receptor–homologous molecule expressed on Th2 cells (CRTH2) did not have any effect, the prostanoid DP–receptor agonist BW245C (0.01 – 1 μM) suppressed TGF-β–induced collagen secretion. PGD2 and BW245C significantly increased intracellular cAMP level. One-hour pretreatment with forskolin (0.1 – 10 μM), dibutyryl-cAMP (0.01 – 1 mM), and the protein kinase A (PKA)-activator N6-phenyl-cyclic AMP (100 μM) significantly reduced TGF-β–induced collagen secretion, while exchange protein activated by cAMP (Epac) activator 8-bromo-2′-Omethyladenosine-3′,5′-cyclic AMP (10 μM) did not affect collagen deposition. These results suggest that PGD2 inhibits TGF-β–induced collagen secretion via intracellular cAMP accumulation through activating DP receptor. Keywords:: prostaglandin D2, lung fibroblast, TGF-β, collagen secretion, prostanoid DP receptor
|
|---|
